XML 47 R31.htm IDEA: XBRL DOCUMENT v3.5.0.2
Business, Basis of Presentation and Business Combinations (Details Textual)
1 Months Ended 12 Months Ended
Apr. 28, 2016
USD ($)
$ / shares
shares
Oct. 31, 2015
USD ($)
Oct. 05, 2015
USD ($)
Sep. 30, 2015
USD ($)
May 31, 2015
USD ($)
Jun. 30, 2016
USD ($)
Jun. 30, 2015
USD ($)
Apr. 28, 2016
CAD
CAD / shares
May 20, 2015
USD ($)
Business Acquisition [Line Items]                  
Stockholders' Equity, Reverse Stock Split           On June 8, 2015, we reincorporated as a domestic Delaware corporation under Delaware General Corporate Law and changed our name from Rosewind Corporation to Aytu BioScience, Inc., and effected a reverse stock split in which each common stockholder received one share of common stock for every 12.174 shares outstanding. On June 30, 2016, Aytu effected another reverse stock split in which each common stockholder received one share of common stock for every 12 shares outstanding (herein referred to collectively as the “Reverse Stock Splits”).      
Payments to Acquire Businesses, Gross           $ 0 $ 1,000,000    
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset           0 664,000    
Amortization of Intangible Assets     $ 174,000     664,707 $ 90,662    
Business Combination, Contingent Consideration, Liability, Total           701,000      
Developed Technology Rights [Member]                  
Business Acquisition [Line Items]                  
Amortization of Intangible Assets           520,000      
Trade Names [Member]                  
Business Acquisition [Line Items]                  
Amortization of Intangible Assets           140,000      
Customer Contracts [Member]                  
Business Acquisition [Line Items]                  
Amortization of Intangible Assets           810,000      
Prostascint Business [Member]                  
Business Acquisition [Line Items]                  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Total         $ 2,400,000       $ 2,391,000
Payments to Acquire Businesses, Gross         1,000,000        
Business Combination, Consideration Transferred, Liabilities Incurred       $ 227,000          
Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, High         $ 2,500,000        
Business Combination Contingent Consideration Percentage         8.00%        
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset         $ 664,000 699,000      
Business Combination Consideration Transferred Product Inventory         $ 500,000        
Jazz Pharmaceuticals Inc [Member] | Prosta Scint [Member] | Developed Technology Rights [Member]                  
Business Acquisition [Line Items]                  
Finite-Lived Intangible Assets, Gross           790,000      
Jazz Pharmaceuticals Inc [Member] | Prosta Scint [Member] | Trade Names [Member]                  
Business Acquisition [Line Items]                  
Finite-Lived Intangible Assets, Gross           80,000      
Jazz Pharmaceuticals Inc [Member] | Prosta Scint [Member] | Customer Contracts [Member]                  
Business Acquisition [Line Items]                  
Finite-Lived Intangible Assets, Gross           720,000      
Primsol Business [Member]                  
Business Acquisition [Line Items]                  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Total     $ 1,799,000            
Payments to Acquire Businesses, Gross   $ 500,000              
Business Combination, Consideration Transferred, Liabilities Incurred   142,000       1,892,000      
Business Combination Consideration Transferred Inventory   102,000       102,000      
Business Combination Consideration Transferred Product Inventory   40,000              
Business Combination Consideration Transferred Work In Process Inventory           80,000      
Primsol Business [Member] | Paid on April 1, 2016 [Member]                  
Business Acquisition [Line Items]                  
Business Combination, Consideration Transferred, Liabilities Incurred   500,000              
Primsol Business [Member] | No Later Than July 01, 2016 [Member]                  
Business Acquisition [Line Items]                  
Business Combination, Consideration Transferred, Liabilities Incurred   500,000              
Primsol Business [Member] | No Later Than September 30, 2016 [Member]                  
Business Acquisition [Line Items]                  
Business Combination, Consideration Transferred, Liabilities Incurred   $ 250,000              
Natesto [Member]                  
Business Acquisition [Line Items]                  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Total           10,500,000      
Payments to Acquire Businesses, Gross $ 2,000,000         5,400,000      
Business Combination, Consideration Transferred, Liabilities Incurred           3,200,000      
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset           $ 3,200,000      
Finite-Lived Intangible Assets, Remaining Amortization Period           8 years      
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares | shares 12,245,411                
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned $ 2,000,000             CAD 2,534,800  
Business Acquisition, Share Price | (per share) $ 0.16             CAD 0.207  
One Time Non-Refundable Payments $ 37,500,000                
Natesto [Member] | First Milestone [Member] | License And Supply Agreement [Member]                  
Business Acquisition [Line Items]                  
One Time Non-Refundable Payments 2,500,000                
Sales Revenue Target 25,000,000                
Natesto [Member] | Second Milestone [Member] | License And Supply Agreement [Member]                  
Business Acquisition [Line Items]                  
One Time Non-Refundable Payments 5,000,000                
Sales Revenue Target 50,000,000                
Natesto [Member] | Third Milestone [Member] | License And Supply Agreement [Member]                  
Business Acquisition [Line Items]                  
One Time Non-Refundable Payments 7,500,000                
Sales Revenue Target 75,000,000                
Natesto [Member] | Forth Milestone [Member] | License And Supply Agreement [Member]                  
Business Acquisition [Line Items]                  
One Time Non-Refundable Payments 10,000,000                
Sales Revenue Target 100,000,000                
Natesto [Member] | Fifth Milestone [Member] | License And Supply Agreement [Member]                  
Business Acquisition [Line Items]                  
One Time Non-Refundable Payments 12,500,000                
Sales Revenue Target 125,000,000                
Natesto [Member] | Second Upfront [Member]                  
Business Acquisition [Line Items]                  
Business Combination, Consideration Transferred, Liabilities Incurred 2,000,000                
Natesto [Member] | Third Upfront [Member]                  
Business Acquisition [Line Items]                  
Business Combination, Consideration Transferred, Liabilities Incurred $ 4,000,000